Latest News
  • eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
  • Generate Life Sciences Establishes Newborn Stem Cell Manufacturing Facility to Support the Development of Personalized Therapeutics
  • Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy Manufacturing
  • eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
cancer treatment images
eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement

eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement Belgium-based eTheRNA immunotherapies has established a collaboration and licence agreement with Ghent University for mRNA delivery with enhanced thermostability, biodegradability and safety. eTheRNA will receive worldwide commercialisation rights for the new generation of lipid nanoparticle (LNP) formulations co-developed with the university’s research group […]

Telix to Acquire US-Based Radiochemistry Firm Optimal Tracers

Excerpt Australia-based Telix Pharmaceuticals has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire Optimal Tracers, a radiochemistry development business providing radiochemistry process development services and research tracers for use in clinical trials. Article Summary The acquisition of Optimal Tracers will bolster Telix’s in-house radiochemistry development capability, by adding a […]

M&A, CGT and Disruptive Drugs Focus for CSL Going Forward

Excerpt Over the past year, CSL has unveiled some big deals that will change the breadth of its focus in a major way. Article Summary The company recently closed an $18.8 billion deal to buy Swiss pharmaceuticals firm Vifor, which makes products for iron deficiency and kidney disease. This was a huge acquisition, and one […]

CSL Brings Next-Gen Vaccines to Australia in $313mn Deal

Excerpt Biotech giant CSL will accelerate investment in messenger-RNA technologies through a $313 million licensing deal with US medicines maker Arcturus Therapeutics, which is developing mRNA vaccines to fight influenza and COVID. Article Summary CSL told investors on Wednesday that its vaccine arm, CSL Seqirus, had inked a deal with Arcturus that would give the […]

Bridgewest Buys Another Pfizer Manufacturing Plant in Australia

Excerpt Two years after acquiring a Pfizer biologics plant in Adelaide, Australia, Bridgewest Group has bought up another Pfizer manufacturing facility in the country. Article Summary The San Diego-based investment firm has agreed to purchase a sterile injectables site near Perth. The facility has extensive blow, fill, seal capabilities and supplies products—including specialty oncology drugs—to […]

Australia to Play Key Role in Moderna’s Next Chapter

Excerpt It’s less than two years since Moderna brought its coronavirus vaccine to the world, but the company’s global chief executive Stephane Bancel has ambitious plans for the company’s next stage of innovation and growth. Article Summary Australia looks set to play a key part in the next chapter of the biotech’s history. After much […]

Wrestling inflation, COVID-19 and the Ukraine conflict, Bayer stocks up to evade future manufacturing bottlenecks: CEO

Article Summary: With hands in pharmaceuticals, consumer health and crop sciences, Bayer has multiple businesses to fall back on in hard times. But that also means the company is exposed to the current confluence of COVID-19, inflation and the Ukraine conflict on multiple fronts. While the German conglomerate achieved gains across all three sectors for […]

UPS’s acquisition of Bomi Group is a done deal

Excerpt: This acquisition adds significant scale to the company’s UPS Healthcare unit, with temperature-controlled facilities in 14 countries, as well as 3,000 new employees throughout Europe and Latin America.   Article Summary: Atlanta-based global freight transportation and logistics services provider said this week it has officially completed its acquisition of Lombardia, Italy-based multinational healthcare logistics […]

UPS heralds new Dublin-based healthcare facility set to open in 2023

Excerpt: Atlanta-based global freight transportation and logistics services provider UPS recently announced that its UPS Healthcare subsidiary is gearing up for an expansion in Ireland, with what it called a Dublin-based “first of its kind healthcare facility” set to open in late 2023.   Article Summary: Atlanta-based global freight transportation and logistics services provider UPS […]

Seven pharma CEOs announce new joint action to accelerate net zero healthcare

Excerpt: CEOs from AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics and Sanofi today announced joint action to achieve near-term emissions reduction targets and accelerate the delivery of net zero health systems. For the first time, the global health sector has come together to reduce greenhouse gas emissions through the Sustainable Markets Initiative (SMI) […]

European energy crisis may portend US drug shortages

Excerpt: Facing winter, aftershocks of the COVID-19 pandemic, a looming recession, soaring energy and transportation costs, and dwindling gas reserves due to Russian supply cuts, some European companies are shuttering plants or scaling down production, fueling fresh fears of essential-drug shortages, according to a new report from the Israel-based drug maker Teva.   Article Summary: […]

Abu Dhabi Airports joins Pharma.Aero

Article Summary: Abu Dhabi Airports has joined Pharma.Aero as a strategic member representing the Middle East. Pharma.Aero is the global membership network for life science and medtech manufacturers, certified cargo communities and airport operators. The collaboration with Pharma.Aero builds on Abu Dhabi’s growth as a global healthcare and life sciences hub, and the success of […]

Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries

Excerpt TAK-003 is advised for use in the EU and in dengue-endemic nations taking part in the EU-M4all procedure to prevent dengue disease in people four years of age and older caused by any dengue virus serotype. Marketing Authorization is anticipated in Europe in the coming months, followed by Regulatory Decisions in Latin America and […]

Explore IMAPAC

    We will send you occasional emails about our Events, Digital Marketing and Market Intelligence services, Upcoming Promotions and important updates about IMAPAC and its partners to keep you in the loop.

    By checking the box above, you acknowledge and agree to IMAPAC’s Terms of Service and to use your contact information provided to communicate with you about offerings by IMAPAC, its brands, affiliates and/or third-party partners consistent with IMAPAC’s Privacy Policy.


    Thought leadership, industry knowledge-sharing and quality networking are at the core of IMAPAC's B2B events.


    In-depth biopharmaceutical industry intelligence brought to you by our team of analysts.

    LeadGen 360

    Expand your influence, be it through branding & display ads, content creation or thought leadership.


    Linking professionals and fostering conversations among the biopharmaceutical industry professionals.